KCNJ10 and type 1 diabetes mellitus: LIPS has even been used to rule out the presence of some autoantibodies in certain diseases including against KIR4.1 in multiple sclerosis [80], IL-2 in T1D [81], and ezrin in pancreatic ductal cancer [82].